The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)

[1]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[2]  C. Angelini,et al.  Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency , 2008, Neurology.

[3]  P. Dean,et al.  X‐Linked myopathy with excessive autophagy: A new hereditary muscle disease , 1988, Annals of neurology.

[4]  E. Ralston,et al.  When more is less: Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease , 2009, Autophagy.

[5]  A. Salminen,et al.  Regulation of the aging process by autophagy. , 2009, Trends in molecular medicine.

[6]  E. Ralston,et al.  Fiber Type Conversion by PGC-1α Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal Muscle , 2010, PloS one.

[7]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[8]  S. Marie,et al.  Deconstructing Pompe Disease by Analyzing Single Muscle Fibers: “To See a World in a Grain of Sand…” , 2007, Autophagy.

[9]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[10]  J. Rilstone,et al.  RETRACTED: VMA21 Deficiency Causes an Autophagic Myopathy by Compromising V-ATPase Activity and Lysosomal Acidification , 2009, Cell.

[11]  S. Tsujino,et al.  [Acid maltase deficiency]. , 2001, Ryoikibetsu shokogun shirizu.

[12]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[13]  D. Metzger,et al.  Autophagy is required to maintain muscle mass. , 2009, Cell metabolism.

[14]  N. Raben,et al.  The values and limits of an in vitro model of Pompe disease: The best laid schemes o’ mice an’ men ……..† , 2009, Autophagy.

[15]  W. Stauber,et al.  Inhibition of lysosomal function in red and white skeletal muscles by chloroquine , 1981, Experimental Neurology.

[16]  M. Komatsu,et al.  Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe disease , 2010, Autophagy.

[17]  S. Dimauro,et al.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) , 2000, Nature.

[18]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Y. Chien,et al.  Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early Treatment , 2009, Pediatrics.

[20]  V. Hill,et al.  Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. , 2008, Human molecular genetics.

[21]  A. Russell,et al.  Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.